Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Updates?

<< Previous

Bullboard Posts

Next >>

Comment by tdon1229on Dec 12, 2020 3:23pm

218 Views

Post# 32093892

RE:RE:RE:RE:RE:RE:RE:Updates?

Pandora wrote:

enriquesuave wrote: "Enveloped viruses can cause persistent infections and must transfer from host to host. Examples of enveloped viruses include ones that cause notorious diseases in humans, such as COVID-19, Influenza, Hepatitis B and C, and Hemorrhagic Fever (Ebola Virus Disease)." As well as HIV, Mumps and measles plus more.

I still find it surprising that they have spent billions to come up with a number of vaccines but in 10 months they have done almost nothing in finding a good therapeutic to fix a person once they contract the disease. Why is that? Why have they totally dragged their feet on this component? It's been the biggest necessity since this whole thing started 10 months ago and the results are pathetic. Even something like CYDY's Leronlimab which has been around for a few years and has a good safety profile from a number of trials has now got to go full time for a 390 patient double blind Phase 2/3 trial and gets not fast track even though their Phase 2B showed good results. It just drags on and on while the death rate keeps growing. Everybody is all twitterpated over the vaccines but they're not helping the sick people.

For further information regarding treatments for COVID and timing of same, go here:

https://swprs.org/on-the-treatment-of-covid-19/

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages